Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERTOLIZUMAB PEGOL for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 2,256 adverse event reports in the FDA FAERS database where CERTOLIZUMAB PEGOL was used for Off label use.

Most Reported Side Effects for CERTOLIZUMAB PEGOL

Side Effect Reports % Deaths Hosp.
Drug ineffective 23,838 24.1% 1,165 3,601
Rheumatoid arthritis 17,782 17.9% 1,735 3,510
Pain 13,929 14.1% 1,494 2,958
Fatigue 11,438 11.5% 1,764 3,013
Off label use 10,281 10.4% 1,629 3,112
Rash 9,663 9.8% 1,679 2,832
Alopecia 9,111 9.2% 1,589 2,504
Maternal exposure during pregnancy 9,013 9.1% 1,288 2,039
Arthralgia 8,993 9.1% 1,591 2,928
Abdominal discomfort 8,615 8.7% 1,581 2,564
Joint swelling 8,607 8.7% 1,690 2,643
Systemic lupus erythematosus 8,212 8.3% 1,760 2,351
Pemphigus 7,869 7.9% 1,564 2,114
Contraindicated product administered 7,783 7.9% 1,059 2,122
Swelling 7,748 7.8% 1,641 2,419

Other Indications for CERTOLIZUMAB PEGOL

Rheumatoid arthritis (47,602) Product used for unknown indication (19,011) Psoriatic arthropathy (10,537) Crohn's disease (8,758) Psoriasis (8,179) Ankylosing spondylitis (7,776) Axial spondyloarthritis (1,313) Colitis ulcerative (432) Juvenile idiopathic arthritis (385) Spondyloarthropathy (309)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033) LACOSAMIDE (842)

Related Pages

CERTOLIZUMAB PEGOL Full Profile All Off label use Drugs CERTOLIZUMAB PEGOL Demographics CERTOLIZUMAB PEGOL Timeline